На главную
Результаты поиска “Coumadin for atrial fibrillation”
Anticoagulation strategies for Atrial Fibrillation [UndergroundMed]
 
06:47
For more videos, check out our website at: http://videos.undergroundmed.net
Просмотров: 2165 UndergroudMed
Atrial Fibrillation, Coumadin®, & the CHADS2 Score--StopAfib.org interviews Dr. Manish Shah
 
04:35
http://www.stopafib.org If you have atrial fibrillation, how do you know your risk of stroke and whether or not you should be taking Coumadin® or warfarin? Dr. Manish Shah talks about the CHADS2 scoring system that addresses this afib controversy and how your doctor will assess your CHADS2 score. Dr. Shah is an electrophysiologist, Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, D.C., and Assistant Professor of Medicine at Georgetown University School of Medicine. StopAfib.org, at http://www.StopAfib.org, is for atrial fibrillation patients by afib patients. A full video transcript can be found at: http://stopafib.org/newsitem.cfm/NEWSID/135
Просмотров: 5671 StopAfib
New Anticoagulants for Stroke Prevention in Atrial Fibrillation | Christian Ruff, MD
 
24:28
"New Anticoagulants for Stroke Prevention in Atrial Fibrillation" Christian Ruff, MD Treatment Options for Atrial Fibrillation and VTE March 4th, 2013 Brigham and Women's Hospital Boston, MA
Просмотров: 10278 NAThrombosisForum
Natural 'Blood thinners' for Afib
 
11:41
This video is about Natural 'Blood thinners' for Afib. In this video, i talk about some natural blood thinners like Garlic, Ginger, Nattokwinase, Hawthorn, Motherwort etc and why i would not recommend them as an alternative to warfarin or the NOACs in patients with Afib
Просмотров: 20126 York Cardiology
Atrial Fibrillation: Coumadin to Prevent Stroke
 
01:18
One of the potential devastating consequences of atrial fibrillation is a stroke. You can prevent a stroke with the use of a blood thinner called coumadin. HeartSmartMD co-founder, author and board certified cardiologist Dr. Matt DeVane explains the risks and benefits of using coumadin to prevent strokes in atrial fibrillation. Learn much more at www.HeartSmartMD.com
Просмотров: 638 HeartSmartMD
Perioperative Management of Anticoagulation: 2016 CCS Atrial Fibrillation Guidelines
 
11:26
Perioperative Management of Anticoagulation in Patients with AF 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Featuring: L. Brent Mitchell, MD Libin Cardiovascular Institute of Alberta University of Calgary, and Alberta Health Services
Просмотров: 1665 Canadian Cardiovascular Society
Atrial Fibrillation & Coumadin® Replacements--StopAfib.org interviews Dr. Manish Shah
 
07:28
http://www.stopafib.org Dr. Manish Shah talks about Dabigatran and Rivaroxaban, new drugs in clinicals trials to replace the blood thinner Coumadin® (warfarin), an anticoagulant frequently used to avoid strokes by those with atrial fibrillation. He talks about the two categories of these new drugs, thrombin inhibitors and Factor Xa (10a) inhibitors. Dr. Shah is Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, D.C., and Assistant Professor of Medicine at Georgetown University School of Medicine. StopAfib.org, at http://www.StopAfib.org, is for atrial fibrillation patients by afib patients. A full video transcript can be found at: http://stopafib.org/newsitem.cfm/NEWSID/135
Просмотров: 4874 StopAfib
How does warfarin help if I have atrial fibrillation?
 
02:33
Specialist Dr John Worthington talks about the anticoagulant medicine warfarin, including how it reduces the risk of stroke in people with atrial fibrillation. Find out more about warfarin at http://www.nps.org.au/warfarin
Просмотров: 661 NPS MedicineWise
9 atrial fibrillation Anticoagulation
 
13:15
Просмотров: 1224 drsarmaji
8 atrial fibrillation Management
 
09:48
Просмотров: 16051 drsarmaji
VIDEO: Natural Alternatives to Coumadin | drsinatra.com
 
01:21
http://www.drsinatra.com/should-you-take-blood-thinning-drugs?key=243983&utm_campaign=youtube&utm_source=content_vid&utm_medium=vid_desc_text_link&utm_content=video-41925-safe alternative to coumadin-vid_desc_text_link Is there a safe, natural alternative to Coumadin? Unfortunately, says Dr. Stephen Sinatra, if you've been prescribed this drug, you will have to remain on it.
Просмотров: 18053 Dr. Stephen Sinatra
What are my options for anticoagulation therapy for Atrial Fibrillation?
 
01:12
Mintu Turakhia, MD, MAS, discusses the difference in oral anticoagulants and anticoagulation therapy that includes a clinic or coach. To connect with other patients visit: http://spr.ly/60598YnMv
Просмотров: 106 American Heart Association
Warfarin Anticoagulation, Dementia, and Atrial Fibrillation
 
05:09
DescriptioDr. Malini Madhavan, an Assistant Professor of Cardiology at Mayo Clinic in Rochester, MN, discusses her article appearing in the February 2018 issue of Mayo Clinic Proceedings which examined the effect of anticoagulation in patients experiencing atrial fibrillation and its relationship to dementia. She found significant reductions in the incidence of dementia in those patients maintaining therapeutic levels of warfarin. She notes further studies are needed for the effects of newer anticoagulants. Available at: https://tinyurl.com/ycjvxykkn
Просмотров: 37 Mayo Proceedings
Exercise "Dose" and Anticoagulation for AFib
 
03:32
Dr. Christopher Cannon discusses articles appearing this week in Circulation, AJC, and in NEJM on exercise "dose" and on anticoagulation for Afib. Christopher P. Cannon, MD, FACC Statements or opinions expressed in this program reflects the views of the contributors and do not reflect the official policy of the ACCF, unless otherwise noted.
Просмотров: 631 American College of Cardiology
Natural Blood Thinners and Atrial Fibrillation/ Stroke Prevention: Did your doc consider these?
 
08:07
ford brewer md mph . PrevMedHeartRisk.com There are a lot of blood thinners in the herbal medicine list: garlic, nattokinase, ginger, cinnamon, cassia, vitamin e, ginkgobiloba, grape seed extract, cayenne, aspirin, apple cider vinegar, cod liver oil, etc. Most of these are antiplatelets, not anticoagulants. Anticoagulants have been shown to be more effective in terms of prevention of strokes. Safety is also an issue. The strokes we're preventing are infarction, embolic, or ischemic strokes. So, we decrease the formation of blood clots. Unfortunately, that also increases the risk for serious bleeding or hemorrhage, such as hemorrhagic strokes. The research has been clear for over 20 years that anticoagulants seem better than antiplatelets for stroke prevention. And most docs will go with the researched recommendations. These days the researched recommendations are leaning more and more toward the NOACs, the New Oral Anti Coagulants. I have other videos in a series on stroke prevention and atrial fib. About Dr. Brewer - Ford Brewer is a physician that started as an Emergency Doctor. After seeing too many patients coming in dead from early heart attacks, he went to Johns Hopkins to learn Preventive Medicine. He went on the run the post-graduate training program (residency) in Preventive Medicine at Hopkins. From there, he made a career of practicing and managing preventive medicine and primary care clinics. His later role in this area was Chief Medical Officer for Premise, which has over 500 primary care/ prevention clinics. He was also the Chief Medical Officer for MDLIVE, the second largest telemedicine company. More recently, he founded PrevMed, a heart attack, stroke, and diabetes prevention clinic. At PrevMed, we focus on heart attack and stroke and Type 2 diabetes prevention by reducing or eliminating risk through attentive care and state-of-the-art genetic testing, imaging, labs and telemedicine options. We serve patients who have already experienced an event as well as those have not developed a diagnosis or event. Our team of senior clinicians includes internationally recognized leaders in the research and treatment of cardiovascular disease, preventive medicine and wellness. We also provide preventive medicine by telemedicine technology to over 30 states. Contact Dr. Brewer at info@prevmedheartrisk.com or visit http://prevmedheartrisk.com.
Просмотров: 3955 Ford Brewer
Atrial fibrillation -- achieving safer anticoagulation
 
33:50
Sunil Rao John Alexander
Просмотров: 137 Duke Clinical Research Institute
Warfarin, Diet and Atrial Fibrillation
 
02:08
James Edgerton, MD discusses diet changes and warfarin with an atrial fibrillation patient. Learn more about AFib patient education at MyAFibExperience.org
Просмотров: 223 American Heart Association
Internal Medicine ABIM Board Exam Review Question: Anticoagulation in Atrial Fibrillation
 
02:46
This video about anticoagulation in atrial fibrillation is directly out of the Knowmedge (http://www.knowmedge.com) Internal Medicine Board Review (ABIM exam) questions qVault. Knowmedge is an online test platform for Internists preparing for their ABIM board exam certification or recertification.
Просмотров: 3095 knowmedge
Anticoagulants for Afib
 
00:37
Просмотров: 8098 Healthline
Goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
 
02:21
Description of goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Просмотров: 572 Diego Belardi
Meds First Line Treatment for AFib
 
01:52
Cardiovascular disease remains the number one killer in this country, and one of the most commonly seen cardio conditions is AFib. An irregular heartbeat, it leads to a higher risk of stroke. “The risks are completely different depending upon a variety of issues including the history of prior stroke, heart failure, high blood pressure, diabetes, vascular disease, age, and gender,” says Lee Memorial Health System cardiologist Dr. Richard Chazal. With the help of a risk calculator, doctors assess each patient. Much research and development is being aimed towards AFib, but the simple truth is, that one of the most basic, time-tested treatments remains the best first line approach. “In 2014, the American College of Cardiology and the American Heart Association released guidelines on treatment of patients with atrial fibrillation. In most cases, patients with minimal symptoms are recommended to be treated with control of the heart rate and also anticoagulant blood thinners to reduce the likelihood of having a stroke,” says Dr. Chazal. At the same time advances are being made in surgical treatments for AFib, R&D is put to use in developing new drugs. These medications are easier to take than in years past. The hope is more people who need them will find drug therapy easier to swallow. “Their advantage is a reduction in the likelihood of interaction with other medications, a reduction in the likelihood of interaction with certain foods or beverages that could be problematic with warfarin or Coumadin, and importantly, the lack of need for regular blood test to monitor the control of the anticoagulant,” says Dr. Chazal. A risky condition, your doctors can recommend the right line of treatment for AFib that will reduce the stress on your health. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we’ve been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Просмотров: 1982 Lee Health
Coumadin (Warfarin): Clinical Pharmacist Explains Everything You Should Know
 
06:31
Dr. Jacqueline DiMarco, clinical pharmacist, explains everything patients should know about the blood thinner Coumadin (warfarin). We cover the mechanism of action against vitamin K, the conditions it treats (including atrial fibrillation and deep vein thrombosis a.k.a DVT), the INR and how it should be monitored, as well as the Lovenox bridge and dietary recommendations. Make sure to check us out on the web at http://www.DoctorVoices.com for the most dependable health information on the internet. This video and all content produced by Doctor Voices is for educational purposes only, please make sure to follow with your doctor for all of your health conditions. Please see our terms of use on our site.
Просмотров: 28144 Doctor Voices
Anticoagulation and risk of bleeding with Atrial Fibrillation
 
01:20
Eric Prystowsky, MD explains important points to keep in mind when weighing the risk of stroke and bleeding risk with anticoagulation for AFib patients.
Просмотров: 88 American Heart Association
AFib, anticoagulants and antidotes
 
21:31
In this video, Dr Sanjay Gupta, discusses the role of different anticoagulants in atrial fibrillation and why the lack of antidotes shouls not put anyone off using the NOACS.
Просмотров: 1446 York Cardiology
6/16/17: Atrial Fibrillation: Can We Organize the Chaos?
 
58:58
Anne O'Connor, MD and Jennifer Wright, MD co-present a lecture about clinical management of atrial fibrillation. Dr. O'Connor is an Associate Professor (CHS) whose clinical interests include critical cardiology, reducing readmissions for heart failure and acute myocardial infarct patients, and cardiovascular imaging. Dr. Wright is a Clinical Assistant Professor who specializes in cardiology and electrophysiology. Both are members of the Division of Cardiovascular Medicine in the Department of Medicine at UW-Madison. The title of their June 16, 2017 Grand Rounds talk is "Atrial Fibrillation: Can We Organize the Chaos?" University of Wisconsin Department of Medicine Grand Rounds are presented throughout the academic year and are intended for health care professionals and medical researchers. Unless otherwise indicated, Grand Rounds occurs in the William S. Middleton Memorial Veterans Hospital auditorium, Room A1028, Madison, Wisconsin. All faculty and staff are invited and encouraged to attend. For more information on the Grand Rounds lecture series, visit http://www.medicine.wisc.edu/dom/medicine-grand-rounds
Просмотров: 1870 UW Department of Medicine
Eliquis: New Medication for Atrial Fibrillation
 
28:18
An in-depth conversation between Pentucket Medical cardiologists Seth Bilazarian and Sunny Srivastava, focusing on a newly released medicine to reduce the risks of atrial fibrillation. The latest among recently approved blood thinners, Eliquis joins Pradaxa and Xarelto as an alternative to Coumadin, a drug that has been in use since the 1950s. Like Pradaxa and Xarelto, Eliquis has been shown to reduce risk of stroke and bleeding, as well as mortality. All the new drugs eliminate the need for regular blood testing that Coumadin necessitates.
Просмотров: 25558 PentucketMedical
Can I take an aspirin for atrial fibrillation?
 
03:54
Join our channel by subscribing here. If you have enjoyed our video, please like it and leave a comment about what other videos you may be interested in. Your help in creating great, relevant content is greatly appreciated. Although it was thought for many years that aspirin was sufficient to 'thin' your blood to prevent blood clots inside the heart from forming, the latest evidence is that aspirin is just not effective enough in people who have atrial fibrillation associated with other risk factors, including being elderly! This video describes the role of aspirin in managing patients with atrial fibrillation. Transcript: Thank you for visiting Doctor AFib, I'm Dr. Morales. In today's video segment we're going to be talking about the role of aspirin when it comes to managing atrial fibrillation. In a previous video segment, I discussed your risk of stroke with atrial fibrillation as defined by the CHADSVASc risk score. Most people who have atrial fibrillation are going to have a CHADSVASc score of two or greater and it's going to be recommended to take stronger blood thinners, something called anticoagulation. However, when I explain it to the patients, probably the next question is: what about an aspirin? Can I take an aspirin for atrial fibrillation? So, let's look at the data regarding aspirin for atrial fibrillation. Aspirin has been studied for atrial fibrillation since the late 80s and early 90s and in multiple clinical trials. Back in 2007, there was a meta-analysis which combined the results of several studies and showed that aspirin provides a reduction in the rate of stroke by about 22%. Most studies in the 80s and 90s used aspirin 325 milligrams daily. A later study called the Active W trial looked at the combination of aspirin together with Plavix and that reduced your risk of stroke by about 44%. However, in that same meta-analysis in 2007, it showed that Warfarin, also called Coumadin, reduced risk of stroke in atrial fibrillation by about 66%. Several studies were done back in the late 80s or 90s early 2000s looking at comparing aspirin with Warfarin and every time Warfarin was found to be superior to aspirin for reducing your risk of stroke. As a result, for many years Warfarin became the standard of care for reducing the risk of stroke because it was far better in terms of the reduction amount for reducing the risk of stroke. Fortunately, these days there are other options, where newer blood thinners have come out as an alternative to Warfarin. Listen to the video for more Read my blog posts at http://www.DrAFib.com
Просмотров: 288 Dr. AFib
AFib: Anticoagulation Strategies - Dallas CVI 2015
 
11:46
Dr. Owen Obel discusses new treatments for atrial fibrillation
Просмотров: 405 Manos Brilakis
The BRIDGE Trial
 
01:36
Patients with atrial fibrillation are at increased risk of stroke. Warfarin anticoagulation is often used to reduce risk, but it is usually stopped perioperatively. Temporary “bridging” with heparin is common, but is it necessary? New research findings are summarized in a short video. See the NEJM article: "Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation": http://www.nejm.org/doi/full/10.1056/NEJMoa1501035
Просмотров: 3520 NEJMvideo
Atrial Fibrillation in Older Adults: Anticoagulation
 
13:46
November 18th, 2016 Michael A. Chen, MD, PhD Associate Professor of Medicine Division of Cardiology Harborview Medical Center University of Washington
Просмотров: 96 NW GWEC
Comparing Eliquis to Warfarin In Atrial Fibrillation Patients
 
07:30
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Просмотров: 2866 MD Magazine
Atrial Fibrillation: Symptoms Treatment Medications
 
22:10
Dr. Alo discusses atrial fibrillation treatment algorithms including many of the newer rate and rhythm control drugs. Also discusses the novel anticoagulation options. Target audience is informed patients and medical professionals. hhtp://MohammedAlo.com
Просмотров: 10177 Mohammed Alo
Cardiac Arrhythmias - The Missed Cause
 
53:06
If you've looked at the research regarding cardiac arrhythmias then you might have noticed that all the doctors and researchers are focused on the heart and the nodes that control heart function, however, Dr. Bergman explains the one thing everyone is missing... The Autonomic Nervous System. Dr. Bergman's Website https://drjohnbergman.com/ Dr. Bergman's Facebook page: https://www.facebook.com/drjohnbergman/ Dr. Bergman's Clinic: http://bergmanchiropractic.com 714-962-5891 Office Hours: Monday 5:15am 6:00pm Tuesday 6:30am 6:00pm Wednesday 5:15am 6:00pm Thursday 5:15am 6:00pm Friday 6:30am 6:00pm Saturday Closed Closed Sunday Closed Closed Dr. Bergman is available for Skype and Phone consultations which you can schedule by using the link below: https://drjohnbergman.com/online-consultations/booking-consultations/ For Media and Business Inquires contact: support@drjohnbergman.com
Просмотров: 132301 Dr. John Bergman
NOACs vs Coumadin (Warfarin) - Preventing Strokes, the #1 cause of disability
 
08:19
ford brewer md mph . PrevMedHeartRisk.com Atrial Fib is the biggest rising cause of disability. High BP is a major cause of strokes as well, but we are managing BP better on a population basis. Anti-coagulants ( not antiplatelets) prevent stroke with a fib. Coumadin has been the big preventive until recently. But it has disadvantages: 35 days to effective levels, weekly blood test monitoring for effectiveness, and significant dietary restrictions re: Vitamin K. Samples include collard greens, spinach, kale, turnip greens, broccoli, and even blueberries, blackberries and tuna. The NOACs are now available. They are dabigatran ( Pradaxa), rivaroxaban (Xarelto), Apixaban ( Eliquis), and Edoxaban (Savaysa). NOAC advantages include: immediate effect, no weekly blood test requirement, fewer ( maybe no) food restrictions, and - most importantly - LESS BLEEDING THAN COUMADIN (including fewer hemorrhagic strokes). The only advantage for coumadin would be an immediate antidote ( Vit K). That's not much of an advantage compared to less bleeding in the first place. Also, Pradaxa already has an immediate antidote. And the other NOACS are scheduled to have immediate antidotes in less than a year. About Dr. Brewer - Ford Brewer is a physician that started as an Emergency Doctor. After seeing too many patients coming in dead from early heart attacks, he went to Johns Hopkins to learn Preventive Medicine. He went on the run the post-graduate training program (residency) in Preventive Medicine at Hopkins. From there, he made a career of practicing and managing preventive medicine and primary care clinics. His later role in this area was Chief Medical Officer for Premise, which has over 500 primary care/ prevention clinics. He was also the Chief Medical Officer for MDLIVE, the second largest telemedicine company. More recently, he founded PrevMed, a heart attack, stroke, and diabetes prevention clinic. At PrevMed, we focus on heart attack and stroke and Type 2 diabetes prevention by reducing or eliminating risk through attentive care and state-of-the-art genetic testing, imaging, labs and telemedicine options. We serve patients who have already experienced an event as well as those have not developed a diagnosis or event. Our team of senior clinicians includes internationally recognized leaders in the research and treatment of cardiovascular disease, preventive medicine and wellness. We also provide preventive medicine by telemedicine technology to over 30 states. Contact Dr. Brewer at info@prevmedheartrisk.com or visit http://prevmedheartrisk.com.
Просмотров: 181 Ford Brewer
Managing atrial fibrillation: Anticoagulation, ablation, and improving quality of life
 
15:37
In a video originally posted on TheHeart.org, Win-Kuang Shen, MD, sits down with Samuel J Asirvatham, MD, and Douglas Packer, MD, for an in-depth discussion of the major issues involved in managing atrial fibrillation, from increasing patient awareness to stroke prevention and when and how to use ablation.
Просмотров: 738 Mayo Clinic
Top Developments in Anticoagulant - Anticoagulation in AF  (Heart&Stroke Clinical Update)
 
26:06
Heart & Stroke Clinical Update 2015 www.heartandstroke.ca/clinicalupdate Plenary 3c Top Developments in Anticoagulant - Oral Anticoagulation for AF-related Stroke Prevention Presented by: Andrew Ha, MD, FRCPC (see below) Hilton Toronto, December 2015 Learning Objectives 1. Review common stroke and bleeding assessment schema for patients with atrial fibrillation (AF). 2. Review randomozed controlled trials comparing the efficacy and safety of warfarin versus noval oral anticoagulants (NOAC). 3. Discussion of “real-world” observational studies on the use of warfarin and NOAC agents. 4. Review the safety and effectiveness of oral anticoagulation in high-risk patient subgroups (e.g. chronic kidney disease). 5. Reversal agents for NOACs Session Description Stroke prevention with oral anticoagulation (OAC) is one of the most important treatment goals in the management of patients with atrial fibrillation (AF). Traditionally, warfarin is the drug of choice for AF-related stroke prevention. Recently, the introduction of novel oral anticoagulant (NOAC) agents has revolutionized this field. As a consequence of the rapid uptake of NOAC agents in clinical practice, health practitioners now face many new questions when prescribing OAC for AF patients with elevated stroke risk. For instance, there is a pressing need to develop a greater understanding of the “real-world” effectiveness and safety between warfarin and NOAC agents. In addition, further delineation of the risks and benefits of warfarin vs. NOAC agents in high-risk AF patient subgroups (e.g. elderly, patients with kidney disease, patients treated with antiplatelet therapy) will be most welcomed. In this session, we will examine data from randomized clinical trials, “real-world” registries, and large-scale health administrative databases to address these keys questions on OAC use for AF-related stroke prevention. Andrew Ha, MD, FRCPC Staff cardiac electrophysiologist, Toronto General Hospital, University Health Network The following information was provided by speakers at the Clinical Update 2015. The information is intended for use by healthcare professionals for reference and education only and is not intended to be a substitute for a physician's advice, diagnosis or treatment. You should consult your physician for personal health matters.
Просмотров: 1477 Heart and Stroke
Dr Foran explains an alternative to anticoagulation treatment
 
06:04
Dr John Foran is a consultant cardiologist. He explains why atrial fibrillation patients are more likely to suffer a stroke as a result of blood clots. Patients are often prescribed with anti-coagulation treatment like warfarin. Now, an alternative treatment called left atrial appendage closure is available. Dr Foran explains the procedure. This video has been produced by Watchman.
Просмотров: 2909 ArrhythmiaAlliance
Reducing stroke risk in atrial fibrillation
 
04:53
Atrial fibrillation (AF) increases stroke risk five-fold. This video explains how this risk could be reduced through appropriate anticoagulation. It features Arrhythmia Alliance and AF Association CEO, Trudie Lobban MBE, AF Association Deputy CEO, Jo Jerrome, leading heart rhythm specialist, Professor John Camm and CEO of Anticoagulation Europe, Eve Knight. Developed in association with Boehringer Ingelheim.
Просмотров: 2275 ArrhythmiaAlliance
Coumadin Monitoring At Home
 
26:51
In this episode of Matters Of The Heart, Pentucket Medical cardiologists Dr. Seth Bilazarian and Dr. Sunny Srivastava engage in a detailed discussion of new devices and medications that may benefit certain types of heart patients. Coumadin, or Warfarin, has been a life-saving medication for millions of patients at risk for stroke or atrial fibrillation. However, Coumadin comes with a burden, requiring regular blood tests so that levels can be kept within safe limits. In the past, monitoring has required regular trips to the doctors office. More recently, home testing devices have become available, and approved (and paid for) by Medicare. (Produced in March of 2011) Pentucket Medical Associates offers Cardiology care in the following locations: Haverhill, MA: (978) 521-3288 RiverWalk in Lawrence, MA: (978) 557-8900 Newburyport, MA: (978) 499-7400
Просмотров: 68 PentucketMedical
Atrial Fibrillation: The Most Common Heart Arrhythmia
 
01:27:20
Diseases of the heart and blood vessels are the leading causes of death and disability in men and women in the United States, but recent data demonstrates that you can have a positive impact on reducing your risk of cardiovascular disease through lifestyle changes. Join us for a comprehensive review of these complex, but now preventable and treatable, conditions. Series: UCSF Mini Medical School for the Public [8/2010] [Health and Medicine] [Show ID: 18544]
Просмотров: 162104 University of California Television (UCTV)
Atrial Fibrillation & Anticoagulants--StopAfib.org interviews Dr. Elaine Hylek
 
08:39
http://www.stopafib.org StopAfib.org interviews Dr. Elaine Hylek of Boston University. A transcript of this video, as well as additional information about the topics discussed, and Dr. Hylek, can be found at: http://www.stopafib.org/newsitem.cfm/NEWSID/349 In this video interview, Dr. Elaine Hylek of Boston University discusses new anticoagulant drugs for stroke prevention in atrial fibrillation. For many years, warfarin (Coumadin) has been the only anticoagulant option for patients. Taking warfarin requires constant monitoring, and it can be a challenge for many patients. In addition to drug-drug interactions and food-drug interactions, warfarin can be affected by illness or heart failure. Dr. Hylek discusses the clinical trials results for two of the new anticoagulants that are alternatives to warfarin. Dr. Hylek is the Director of Thrombosis and Anticoagulation Services at the Boston Medical Center, and is an Associate Professor at of Medicine at Boston University.
Просмотров: 2344 StopAfib
Bridging Anticoagulation
 
06:13
ISTH 2015 - Thomas Ortel, Chief, Division of Hematology, Professor of Medicine and Hematology and Medical Director, Clinical Coagulation Laboratory, Duke University Medical Center - The management of patients with atrial fibrillation on warfarin who need treatment interruption for surgery/procedure is a common clinical problem. Bridging with low-molecular-weight heparin has been used to minimize the time that patients are not anticoagulated to mitigate the risk for arterial thromboembolism. This study seeks to determine the efficacy and safety of bridging anticoagulation.
Просмотров: 2429 Thrombosis.TV
Atrial Fibrillation Patients Are at Increased Risk of Dementia, Regardless of Anticoagulation Use
 
01:12
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions. Researcher and electrophysiologist Jared Bunch, MD, with the Intermountain Medical Center Heart Institute, explains the study, which was presented at the American Heart Association Scientific Sessions in New Orleans.
Просмотров: 68 Healthy Dialogues
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
 
01:59
Catheter ablation is an invasive procedure; patients usually receive periprocedural anticoagulants for several weeks. New research findings are summarized in this short video. Full study: http://nej.md/2nsLuSz Watch more Quick Take videos: http://nej.md/quick-take
Просмотров: 2354 NEJMvideo
Catheter Ablation of Atrial Fibrillation
 
49:16
Dr. Kneller discusses comprehensive management strategy for atrial fibrillation, including anticoagulation, anti-arrhythmic drug therapy, continuous monitoring of atrial fibrillation with the Medtronic Reveal LINQ, and strategies for catheter ablation of atrial fibrillation including optimal use of the CARTO V3 mapping system.
Просмотров: 3291 JamesKnellerMD
MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION (Peter Leong-Sit) H&S Clinical Update 2016
 
25:25
Heart&Stroke Clinical Update www.heartandstroke.ca/clinicalupdate Hilton Toronto, December 2016 MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION Presented by: Peter Leong-Sit MD, MSc, FRCPC, FHRS (see below) Learning Objectives: 1.To review management strategies for atrial fibrillation 2.To identify good candidates for rhythm control or ablation for atrial fibrillation 3.To provide an overview of atrial fibrillation ablation principles 4.To provide an overview of invasive options for stroke prevention Peter Leong-Sit MD, MSc, FRCPC, FHRS Associate Professor Western University Cardiologist London Heart Rhythm Program The following video was provided with the permission of the speaker. The information is intended for the use of healthcare professionals for reference and education only and is not intended to be a substitute for healthcare professional advice, diagnosis or treatment. You should consult your healthcare professional for personal health matters.
Просмотров: 205 Heart and Stroke
Anticoagulation Choice - Demo
 
08:09
A video demonstration of shared decision making about anticoagulation in atrial fibrillation using the Anticoagulation Choice conversation aid. For more information, visit http://www.mayo.edu/research/labs/knowledge-evaluation-research-unit/overview?mc_id=us&utm_source=youtube&utm_medium=sm&utm_content=video&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100504
Просмотров: 152 Mayo Clinic
Treatment Guidelines for Atrial Fibrillation, AF Patients
 
00:43
Treatment Guidelines for Atrial Fibrillation, AF Patients: Current ESC Guidelines for patients with atrial fibrillation explicitly recommend an oral anticoagulant for patients with two additional risk factors. And in patients with one additional risk factor an oral anticoagulant is recommended in preference to aspirin. Yet only half of all patients who need an anticoagulant, as defined by guidelines, actually receive one. Not surprisingly, it turns out that only one in ten people with AF who suffer a stroke were receiving adequate anticoagulant protection at the time. References: Gladstone DJ, B ui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009;40(1):235-240. Waldo AL, Becker RC, Tapson VF, et al; NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46(9):1729-1736. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360-1420.
Просмотров: 16559 Thrombosis Adviser